StockNews.AI
LFMD
StockNews.AI
6 days

Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD

1. Rosen Law Firm investigates LifeMD for potentially misleading business information. 2. Shareholders may seek compensation through a class action lawsuit. 3. LifeMD revised revenue guidance downward, causing significant stock price drop. 4. Stock plummeted 44.8% following disappointing financial results announcement. 5. Rosen Law has a track record of successful securities class action settlements.

8m saved
Insight
Article

FAQ

Why Very Bearish?

The dramatic 44.8% drop in stock price indicates significant loss of investor confidence. Past examples show that similar investigations can cause prolonged negative market sentiment.

How important is it?

Given the significant stock price movement and the ongoing investigation, it's likely this news will heavily influence investor behavior. Legal risks paired with revenue guidance cuts typically lead to substantial negative sentiment.

Why Short Term?

The immediate fallout from the stock drop suggests quick reactions from investors. Recent historical trends indicate that stock prices can stabilize after initial reactions to legal investigations.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ:LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public.

So What: If you purchased LifeMD securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=43404 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

What is this about: On August 5, 2025, after the market closed, LifeMD reported its financial results for the second quarter of 2025. In this announcement, LifeMD announced revised guidance. Among other metrics, LifeMD stated that it was expecting total revenue in the range of $250 to $255 million, compared with previous guidance of $268 to $275 million.

On this news, the price of LifeMD stock plummeted 44.8% on August 6, 2025.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

case@rosenlegal.com

www.rosenlegal.com

Related News